SEC Form 4 · accession 0001144204-18-014478
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Reichling
Officer — CHIEF FINANCIAL OFFICER
Period of report
Mar 7, 2018
Accepted (ET)
Mar 13, 2018 · 9:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $25.95 | Mar 7, 2018 | A | 8,032 | A | Mar 7, 2018 | Mar 7, 2028 | Common Stock | 8,032 | 8,032 | D |
| Employee Stock Option (right to buy)F1 | $25.95 | Mar 7, 2018 | A | 20,000 | A | — | Mar 7, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The options vest in five (5) equal annual installments on each anniversary of the date of grant beginning on March 7, 2019.